Mortality from inflammatory bowel diseases
- PMID: 22275300
- DOI: 10.1002/ibd.22871
Mortality from inflammatory bowel diseases
Abstract
Ulcerative colitis (UC) and Crohn's disease (CD) may directly result in morbidity and rarely mortality from complications such as colorectal cancer or sepsis. Mortality rates compared with the matched general population, measured by standardized mortality ratio, may therefore be increased. This review examines the evidence derived from cohort- and population-based mortality studies. In CD the majority of studies and two meta-analyses demonstrated increased standardized mortality ratios of ≈ 1.5-fold, especially for those diagnosed at younger ages and requiring extensive or multiple resection surgery. In UC mortality rates are similar to those of the general population in most studies and a meta-analysis. Proctocolectomy removes the inflammatory burden of UC and can manage colorectal dysplasia but may result in perioperative complications. There is no clear temporal trend of improvement in survival for either CD or UC. Few data are available from countries outside Europe and North America, so geographical influences remain largely unknown.
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Similar articles
-
Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010.Clin Gastroenterol Hepatol. 2013 Jan;11(1):43-8. doi: 10.1016/j.cgh.2012.09.026. Epub 2012 Sep 27. Clin Gastroenterol Hepatol. 2013. PMID: 23022699
-
Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland.J Crohns Colitis. 2014 Sep;8(9):1088-96. doi: 10.1016/j.crohns.2014.02.015. Epub 2014 Mar 12. J Crohns Colitis. 2014. PMID: 24630486
-
Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Québec, Canada.Inflamm Bowel Dis. 2016 Feb;22(2):416-23. doi: 10.1097/MIB.0000000000000608. Inflamm Bowel Dis. 2016. PMID: 26484635
-
Chronic inflammatory bowel disease and cancer.Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Hepatogastroenterology. 2000. PMID: 10690586 Review.
-
Inflammatory bowel disease cause-specific mortality: a primer for clinicians.Inflamm Bowel Dis. 2014 Dec;20(12):2483-92. doi: 10.1097/MIB.0000000000000173. Inflamm Bowel Dis. 2014. PMID: 25185685 Free PMC article. Review.
Cited by
-
The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature.Clin Exp Gastroenterol. 2013 Sep 20;6:195-200. doi: 10.2147/CEG.S49202. eCollection 2013. Clin Exp Gastroenterol. 2013. PMID: 24068873 Free PMC article.
-
Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990-2019.Ann Gastroenterol. 2024 Sep-Oct;37(5):527-535. doi: 10.20524/aog.2024.0909. Epub 2024 Aug 19. Ann Gastroenterol. 2024. PMID: 39238799 Free PMC article.
-
Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.Dig Dis Sci. 2019 Jun;64(6):1604-1611. doi: 10.1007/s10620-018-5430-8. Epub 2019 Jan 2. Dig Dis Sci. 2019. PMID: 30604370
-
Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.Pharmacoeconomics. 2020 Jan;38(1):69-84. doi: 10.1007/s40273-019-00841-1. Pharmacoeconomics. 2020. PMID: 31552601 Free PMC article.
-
Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study.J Transl Med. 2019 Dec 12;17(1):414. doi: 10.1186/s12967-019-02164-3. J Transl Med. 2019. PMID: 31831015 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources